Why PetMed Express Is Ready to Rebound

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, nationwide pet pharmacy PetMed Express (NASDAQ: PETS  ) has earned a respected four-star ranking.

With that in mind, let's take a closer look at PetMed and see what CAPS investors are saying about the stock right now.

PetMed facts

Headquarters (Founded)

Pompano Beach, Fla. (1996)

Market Cap

$221.9 million


Internet retail

Trailing-12-Month Revenue

$233.6 million


CEO Menderes Akdag (since 2001)
CFO Bruce Rosenbloom (since 2001)

Return on Equity (Average, Past 3 Years)


Cash / Debt

$62.5 million / $0

Dividend Yield


Competitors (NASDAQ: AMZN  )
KV Vet Supply

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 97% of the 887 members who have rated PetMed believe the stock will outperform the S&P 500 going forward.

Just yesterday, one of those Fools, hend6, succinctly summed up the PetMed bull case for our community: "A very solid balance sheet, despite a lower year-over-year net income, mixed with a great dividend offering. As more people shift to online ordering, and as the younger generation continues to move out and get pets, services like these are posed to thrive."

If you want market-thumping returns, you need to put together the best portfolio you can. Of course, despite a strong four-star rating, PetMed may not be your top choice.

We've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2013." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 23, 2013, at 8:36 AM, PETVET1111 wrote:

    That is so wrong.As I have stated before,their business plan is obsolete.No only is there significant ad price pressure,as well as other online competitors,but many drug companies are now demanding veterinarians sign agreements(which if they break they will be cut off) saying they will not sell to PETS.Merck is the latest.They are selling a revolutionary flea product,a new chemical that is safer and faster.PETS will have no part of that market.PETS selection of medicines are slowly becoming outdated, and certainly no longer cheap.

    So rebound. Sorry

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2209014, ~/Articles/ArticleHandler.aspx, 9/26/2016 8:55:04 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 18,261.45 -131.01 0.00%
S&P 500 2,164.69 -12.49 0.00%
NASD 5,305.75 -33.78 0.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/23/2016 4:00 PM
PETS $20.79 Down -0.11 +0.00%
PetMed Express CAPS Rating: ****
AMZN $805.75 Up +1.05 +0.00% CAPS Rating: ****